Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in JapanArticle Published on 2022-10-052022-11-16 Journal: Medicina [Category] COVID19(2023년), SARS, 변종, [키워드] 113 patient and post COVID-19 condition caused change changes in Characteristics characterized cough COVID COVID patient COVID-19 delta variant dysgeusia dysosmia fatigue Frequency hospitalizations illnesses Insomnia Japan Long manifestation material Myalgic encephalomyelitis/chronic fatigue syndrome objective omicron Omicron variant outpatient clinic Patient patients prevalent Result retrospective significantly significantly lower single-center Symptom syndrome the patient three groups university vaccination variant variants viral variant were infected [DOI] 10.3390/medicina58101393 PMC 바로가기
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal AntibodiesArticle Published on 2022-10-042022-11-15 Journal: Transplant International [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Administered Charlson Comorbidity Index complications COVID-19 COVID-19-related symptom death Diagnosis dose early administration early treatment Epidemiology Hospitalization incidence increased risk Infection kidney Kidney transplantation mAb mAbs monoclonal monoclonal antibodies monoclonal antibody Multivariate analysis Omicron variant onset of symptoms outcome Patient primary endpoint Primary outcome recipient role SARS-CoV-2 SARS-COV-2 infection significant decrease study period the SARS-CoV-2 Transplant vaccination [DOI] 10.3389/ti.2022.10721 PMC 바로가기
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccinationArticle Published on 2022-10-042022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] administration Adverse adverse effect anti-RBD Anti-RBD IgG antibody Antibody Response Arm ARMS binding domain BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 comparable Concentration conducted CoronaVac country COVID COVID vaccine COVID-19 COVID-19 vaccine COVID-19 vaccines dose Effect Effects eligible exploratory first dose fractional dose vaccination Frame Heterologous heterologous regimen highest homologous IgG immunogenic implication IMPROVE Intradermal intradermal vaccination intradermal vaccine intramuscular intramuscular vaccination less lowest of BNT162b2 Omicron variant pilot study Population Protein regimen regimens reported Safe Safety SARS-CoV-2 variants second dose spike Standard dose Study participants systemic adverse reaction T-cell Response the SARS-CoV-2 undetectable vaccination Vaccine vaccine immunogenicity vaccine safety [DOI] 10.3389/fimmu.2022.1010835 PMC 바로가기
Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2퀸즐랜드의 무리 면역 요구 사항 모델링: 백신 접종 효과의 영향, SARS-CoV-2의 주저 및 변종Article Published on 2022-10-032022-09-11 Journal: Philosophical transactions. Series A, Mathematical [Category] COVID19(2023년), SARS, 변종, [키워드] agent Agent-based Modelling Alpha approach assumed Australia Coverage COVID-19 COVID-19 vaccination death decrease Delta Effective vaccines Effectiveness Epidemics example Formula Health herd immunity Herd immunity threshold Hesitancy Hospitalization hospitalizations Immunity IMPROVE Increases increases in Infection infections Intervention Isolation less omicron Omicron variant outbreak Outbreaks outcomes quarantine question raised realism reduced reductions in SARS-CoV-2 text tracing vaccination Vaccine variants variants of concern variants of SARS-CoV-2 widespread [DOI] 10.1098/rsta.2021.0311 PMC 바로가기 [Article Type] Article
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the worldArticle Published on 2022-10-032022-11-16 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome appear approval approved coronavirus coronavirus disease country COVID-19 COVID-19 outbreak COVID-19 vaccine death deaths delta variant disease disease severity distribution drug Effect effective Effectiveness effort Emergency use fatality health emergency health system healthcare hospitalisation Hospitalization individual Omicron variant Omicron variants outbreak pandemic Prevent PROTECT provided reduced remained researcher SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severe disease severity Spread Uncertainty vaccination Vaccine Vaccine development vaccine platform Vaccines variant variant of concern World Health Organisation [DOI] 10.3389/fimmu.2022.961198 PMC 바로가기
SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern BrazilArticle Published on 2022-10-032022-11-16 Journal: PLoS Neglected Tropical Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] addition Analysis Brazil caused Characteristics coronavirus 2 develop diagnosed effective evade genomic individual Infection Lineage natural infection nine occurred omicron Omicron variant outbreak positive Primary infection protective immune response Reinfection respiratory Rio Grande SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 mutation selected Sequencing tested upper respiratory symptom vaccinated individual vaccination Vaccine-induced immunity Vaccines variant variants of concern virus [DOI] 10.1371/journal.pntd.0010337 PMC 바로가기
Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variantArticle Published on 2022-10-012022-11-16 Journal: International forum of allergy & rhinology [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval Characteristics chemosensory clinical presentation coronavirus disease Coronavirus disease 2019 COVID-19 diffusion dropped dysfunction evaluated impairment Infection Mild-to-moderate olfactory olfactory dysfunction omicron Omicron variant outcomes Patient patients positive Prevalence Prospective reported SARS-CoV-2 sense of smell sense of taste severity significantly significantly lower Smell study cohort subject Taste taste dysfunction variant widespread [DOI] 10.1002/alr.22995 PMC 바로가기
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant심장 이식 수혜자를 대상으로 6개월 동안 세 번째 BNT162B2 코로나19 백신에 대한 세포 및 체액 반응의 동역학 - 오미크론 변종에 대한 영향Article Published on 2022-10-012022-11-15 Journal: The Journal of heart and lung transplantation : th [Category] COVID19(2023년), SARS, 백일해, 변종, 진단, 파상풍, [키워드] accelerate applied BNT162b2 BNT162b2 vaccine Bonferroni method cellular continuous variable COVID-19 vaccine declined dichotomous variables dose effective elicited geometric mean titer GMT Heart transplantation Humoral response immune response implication Kinetics Kruskal-Wallis test mRNA vaccines neutralization Neutralizing Neutralizing activity omicron Omicron variant percentage recipient remained SARS-CoV-2-specificT-cell sera serum sustained T-cell Response transmissible variant vaccination variant wild-type wild-type virus [DOI] 10.1016/j.healun.2022.05.014 PMC 바로가기
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review오미크론의 분자적 측면, 백신 개발 및 재조합 균주 XE: 검토Review Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] ACE2 affinity antibody resistance B.1.1.529 booster Booster vaccine COVID-19 CRISPR decrease dosage Efficiency elicited epidemiological Evolution feature genomic global pandemic Infection Mutation omicron Omicron variant Prevalence rate of infection RBD region recombinant variants reduce Research research and development several variant several variants South Africa specific mutations spike region strain T-cell immunity Transmission utilization Vaccine Vaccine development Vaccines variant variant of COVID-19. variant-specific vaccine variant-specific vaccines virus with COVID-19 [DOI] 10.1002/jmv.27936 PMC 바로가기 [Article Type] Review
Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessmentSARS-CoV-2 스파이크 감염성 및 병원성의 오미크론(BA.1) 및 하위 변이체(BA.1.1, BA.2 및 BA.3): 비교 시퀀스 및 구조 기반 계산 평가Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 binding acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis angiotensin BA.1 BA.2 BA.3 BA1.1 bind binding affinity bronchial cells computational tool computational tools contribute contributing to coronavirus COVID-19 Deleterious domain Effectiveness electrostatic expressed Factor hACE2 higher affinity human ACE2 human Angiotensin-converting enzyme Human angiotensin-converting enzyme 2 hydrogen hydrogen bonds indicate Interaction K417N less lineages Lower respiratory tract lung mutated Mutation mutations N-terminal domain N501Y negative NTD omicron Omicron variant pathogenicity positive predicted Q498 RBD RBM receptor receptors residue residues Salt Bridge SARS-CoV-2 SARS-CoV-2 spike sequence severe acute respiratory syndrome Coronavirus significantly Spike protein Spread surface potential T478K the RBD the spike protein thought Transmission transmission potential variant variants wild-type [DOI] 10.1002/jmv.27927 PMC 바로가기 [Article Type] Article